Never Wait for a Diagnosis Again.
Real-time Biopsy Quality Assessment with Bioptic™
Real-time Biopsy Quality Assessment with Bioptic™
On average, 20-25% of all biopsies are inadequate for diagnosis due to lack of on-site quality assessment. Patients are frequently readmitted, re-biopsied, and endure weeks of intermediary stress.
The average pathologist has a billing potential of $638 per hour, due mostly to work performed in the pathology lab. While performing on-site evaluation, pathologists bill at a mere $88 per hour — just 14% of the national average.
There are 2.7M fine-needle aspirated biopsies collected each year; each procedure has direct costs of $3,000 per procedure. The aggregate cost of repeat procedures and unnecessary surgeries amounts to $1.6B annually.
Of all Thyroid surgeries (i.e., a thyroidectomy) following an indeterminate biopsy, 92% are later found to be unnecessary. At $11,000 per surgery, stand to lose $165M annually on these unwarranted procedures.